Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration

Hydrocortisone has long been the treatment of choice for congenital adrenal hyperplasia (CAH). However, treatment with this medication remains problematic. Patients with 21-hydroxylase deficiency CAH have significant diurnal variation in the secretion of 17-hydroxyprogesterone (17OHP). When consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuqua, John S., Rotenstein, Deborah, Lee, Peter A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850127/
https://www.ncbi.nlm.nih.gov/pubmed/20379352
http://dx.doi.org/10.1155/2010/712549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850127/
https://www.ncbi.nlm.nih.gov/pubmed/20379352
http://dx.doi.org/10.1155/2010/712549

Ejemplares similares